Odyssey Therapeutics Funding: $726M Raised, Series D (2025)
Odyssey Therapeutics is a Biotech company based in Boston, Massachusetts. It has raised $726M in total funding. Latest round: Series D.
Odyssey Therapeutics funding overview
Odyssey Therapeutics is a Biotech company based in Boston, Massachusetts. Odyssey Therapeutics has raised $726M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in September 2025. The round record for Odyssey Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Affinity Asset Advisors, Dimension Capital, Jeito Capital, Lightspeed Ventures, TPG Life Sciences Innovations, Wedbush Healthcare Partners and 1 others. 7 distinct backers are named across the disclosed rounds.
Frequently asked about Odyssey Therapeutics funding
How much has Odyssey Therapeutics raised?
Odyssey Therapeutics has raised $726M in total disclosed funding across the rounds on record.
Who has invested in Odyssey Therapeutics?
Affinity Asset Advisors, Dimension Capital, Jeito Capital, Lightspeed Ventures, TPG Life Sciences Innovations, Wedbush Healthcare Partners are named among the investors backing Odyssey Therapeutics.
What was the latest Odyssey Therapeutics funding round?
The most recent disclosed round is a Series D, announced in September 2025.
Where is Odyssey Therapeutics based?
Odyssey Therapeutics is based in Boston, Massachusetts.
What sector does Odyssey Therapeutics operate in?
Odyssey Therapeutics is tracked under Biotech from Boston, Massachusetts, with $726M in disclosed funding.
When did Odyssey Therapeutics last raise?
The last disclosed Odyssey Therapeutics round closed in September 2025 at Series D.
Totals shown for Odyssey Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
